Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
CTORthis companyCitius Oncology, Inc.	$0.55	-5.97×	3.32×	0×	-6.33×	-82.3%	0.0%	0.0%	0.0%	-55.2%	-45.7%	-3.7%	0.08×	0.01×	-107.89×	0.56×	0.0%	3	-2.3	2	C
ACTUActuate Therapeutics Inc	$0.33	-5.77×	16.24×	0×	-5.22×	57.8%	0.0%	0.0%	0.0%	-280.5%	-270.1%	-14.9%	0.05×	0.57×	-1,110.88×	2.39×	0.0%	2	-56.06	2	C
FATEFate Therapeutics, Inc.	$1.95	-0.85×	0.56×	17.56×	-1.16×	-121.9%	-94.1%	-2222.4%	-2051.1%	-65.8%	-51.4%	-96.0%	0.38×	-0.25×	0×	5.79×	0.0%	3	-8.27	1	C-
LNSRLENSAR Inc	$5.50	-4.05×	-5.34×	2.38×	-4.33×	-927.5%	46.4%	-42.1%	-58.7%	131.7%	-77.8%	-10.7%	-0.11×	0.34×	0×	1.15×	0.0%	5	0.85	4	A-
MCRBSeres Therapeutics, Inc.	$1.95	23.25×	2.98×	167.07×	17.2×	-266.7%	-423.8%	-11910.1%	721.9%	12.9%	-72.7%	0.7%	1.88×	3.78×	0×	2.56×	0.0%	3	-14.74	1	C-
OWLTOwlet, Inc.	$4.24	-7.23×	8.53×	2.86×	-7.84×	-829.6%	50.6%	-7.8%	-37.5%	-112.1%	-15.9%	-3.7%	0.37×	0.63×	-2.42×	1.85×	0.0%	4	-1.81	1	C-
Peer median	—	-4.05×	2.98×	2.86×	-4.33×	-266.7%	0.0%	-42.1%	-37.5%	-65.8%	-72.7%	-10.7%	0.37×	0.57×	0×	2.39×	0.0%	3	-8.27	1	—